According to the latest report by Renub Research titled, “Lung Cancer Screening Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis” the Global Lung Cancer Screening Market Size was US$ 15.4 Billion in 2021. Lung cancer is the ultimate cause of cancer death among both women and men globally. Thus, lung cancer screening aims to detect lung cancer before it has spread; this can help find cancer early. However, the only recommended screening test for lung cancer is low-dose computed tomography (also called a low-dose C.T. scan, or LDCT), Chest x-ray, and Sputum cytology. Screening with LDCT scans has been conferred to decrease the risk of dying from lung cancer in heavy smokers. Screening by chest x-rays and sputum cytology does not reduce the risk of dying of lung cancer. Furthermore, lung cancer screening is a method used to detect lung cancer in otherwise healthy people with a high risk of lung cancer. Worldwide Lung Cancer Screening Industry to Grow with a CAGR of 1.4% from 2021 to 2027 According to Statista the increasing incidence of lung cancer death is one of the significant factors driving the lung cancer screening industry. For instance, in 2020, around 1.79 Million cancer deaths, or 18% of all cancer deaths worldwide, were attributed to lung cancer. Further, the increasing number of screening test approvals from regulatory bodies is to drive the growth of the lung cancer screening market. For instance, in 2021, the U.S. Food and Drug Administration (FDA) announced approval for Amgen’s Sotorasib to treat patients with metastatic non-small cell lung cancer (NSCLC) or locally advanced with KRAS G12C mutation. Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=lung-cancer-screening-market-p.php Non-small Cell Lung Cancer (NSCLC) Segment Holds the Lion’s Share Based on cancer type, the global lung cancer screening market is segmented into non-small cell lung cancer (NSCLC) and small cell lung cancer. For instance, according to the (ACS) American Cancer Society, about 84% of all lung cancers are non-small cell, and 13% are SCLC. The growing awareness about screening in developed and developing countries combined with the ever-increasing cases of NSCLC across the globe demand for screening lung cancer type is done with a test called a spiral computed tomography or low-dose helical (C.T. or CAT) scan. Healthcare like Hospitals & Clinics, Research institutes, and Diagnostic Centers play an active role in making people aware and educated about lung cancer screening. Doctors used conventional chest X-rays to check for signs of lung cancer, such as a suspicious spot. While traditional X-rays help detect lung cancer, they offer less detailed pictures from one angle than more advanced imaging technology, like C.T. scans, that use X-rays from multiple angles to make clear images of the lungs. Moreover, because of the National Lung Screening Trial and support from leaders in lung cancer treatment and prevention, low-dose C.T. scans of the chest are a standard of care in hospitals across the world. Lung Cancer Incidence and Mortality in China have been Increasing Rapidly Geographically, United States holds the most crucial requirement for lung cancer screening due to the rising lung cancer cases, progressing implementation of technologically advanced solutions and robust application of cancer screening courses, which are few of the aspects accountable for the domination of United States. For instance, as per the American Society of Clinical Oncology (2020), lung cancer is the second greatest basic cancer occurring in men and women and was assessed to affect more than 235,000 adults in the U.S. In Germany, the lung cancer screening industry has grown due to increasing cancer awareness and introducing new medical diagnostic equipment and advanced therapies. The expanding elderly population, changing lifestyles, and rising tobacco smoking, including passive smoking, are likely drivers for the German lung cancer screening market. Likewise, as per the Global Cancer Observatory (Globocan), around 64,804 new cases of lungs cancer were identified in Germany in the year 2020. COVID-19 Outbreak: The outbreak of COVID-19 has hindered the lung cancer screening market since its arrival. This pandemic has created a commotion in the supply chain of clinical material. Consequently, there has been a rise in demand for global imaging solutions. Nevertheless, disruption in production and the industrial procedure has led to a disadvantageous impact on the market globally. Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/lung-cancer-screening-market-p.php Robust Portfolio, Strong Distribution Network, and New Product Launch to help Key Players Lead The global lung cancer screening market is consolidated with key players, including llumina, Inc, Abbott Laboratories, Thermo Fisher Scientific, Inc, QIAGEN N.V. and Roche Holding AG. The dominance of these major companies is attributed to the strong product portfolio of screening devices, robust distribution network, mergers and acquisitions, and introduction of new products in the market. Market Summary: Cancer Type - We have covered Global Lung Cancer Screening Market breakup by 2 viewpoints by Cancer Type (Non-small cell lung cancer (NSCLC) and Small cell lung cancer) End User - Renub Research Report has covered by End User in the 4 viewpoints (Hospitals & Clinics, Research institutes and Diagnostic Centers and Others) Country – Our Report has covered Lung Cancer Screening Market breakup by 3 countries (United States, Canada, Norway, Italy, France, Germany, United Kingdom, Russia, Spain, China, India, Japan and South Korea) All the key players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) llumina Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, QIAGEN N.V. and Roche Holding AG. About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND) Email: info@renub.com Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research Follow on Twitter: @renubresearch

According to the latest report by Renub Research, “4K Medical Imaging Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis” the 4K Medical Imaging Market is expected to be USD 1.7 Billion by 2027. Digital medical imaging technology has grown rapidly in the last few decades and is widely used as a medical diagnostic tool. The medical enterprise is in the throes of entering a unique epoch in imaging technology. Healthcare specialists are upgrading to ultra-high-definition 4K resolution as innovative technology delivers four times more clarity than high definition. 4K imaging is a display panel that delivers high-definition video.The 4K technology has changed the perspective of the healthcare sector. The technology allows access of images that will ultimately help in providing efficient treatment. Further, imagine seeing tissue, blood vessels, and organs in detail in richer detail than full HD. The sharper 4K picture provides a more real-to-life clarity of color and detail, making microsurgical crucial in minimally invasive and general surgery procedures. Now everyone in the OR (operating room) can have a better realistic view of the procedure. Video and still images caught and displayed in 4K give surgeons and clinical staff enhanced perception of fine details during complex procedures with virtually no pixilation. Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=4k-medical-imaging-market-p.php Factors Influencing the 4K Medical Imaging Industries The increasing need for hybrid operational rooms is the primary factor that will benefit the global 4K medical imaging industry. Rising healthcare expenditure is forecast to offer ample opportunities for companies flourishing in the global . The 4K medical imaging market is witnessing increasing demand for visualization quality for medical imaging. Furthermore, growing cases of chronic diseases increase the demand for technologically advanced products. The rising demand for flexible designs of 4K medical imaging technology will propel the market growth during the forecast period. COVID-19 Impact on 4K Medical Imaging Growth Rate The COVID-19 pandemic has resulted in economic disruption for various countries. This worldwide pandemic has suddenly burdened the healthcare bodies and caused the governments to focus on the COVID-19 related healthcare infrastructure. Due to this the demand for 4K imaging technologies has decreased for a short period of time. Disruptions in the supply chain also reduced market development. Due to labor unavailability and raw materials, various manufacturing companies had to halt the activities. Therefore, it impacted the global 4K medical imaging industry. Worldwide 4K Medical Imaging Market Size was USD 855.8 Million in 2021 Based on type, the 4K medical imaging market is segmented into 4K camera systems, 4K medical displays, and 4K Advanced Visualization Systems (Microscopic Systems). The 4K medical displays are growing immensely in the 4K medical imaging industry due to the fast adoption of hybrid operating rooms. It provides various advantages such as integrating different facilities, time, and cost-effectiveness. Similarly, the patients’ data of other devices are displayed on the desired display and offers better visualization quality, further propelling the blossoming of the 4K medical imaging market. Likewise, the 4K medical display market includes medical displays 4K UHD (3840*2160) and 4K DCI (4096*2160) medical displays. North America 4K Medical Imaging Market is Driving the Growth Worldwide Geographically, North America is the most considerable market for 4K medical imaging, owing to the growing demand for advanced technology in the region healthcare sector. In addition, favorable government initiatives increased healthcare expenditure, and prominent players like STERIS would contribute to the market development. The rising awareness about the benefits and high-resolution properties of 4K medical imaging technology further boosts the devices' demand. Moreover, the increasing geriatric population and the growing prevalence of chronic diseases will benefit the regional market. Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/4k-medical-imaging-market-p.php Competitive Landscape The primary players covered in the 4K medical imaging industry are Sony Corporation, B. Braun Melsungen, Stryker Corporation, Smith & Nephew plc, Eizo Corporation, Stryker, Conmed Corporation, Medtronic plc, Siemens Healthineers, Zimmer Biomet Holdings, Inc. Market Summary: Type - We have covered Market breakup by 4 viewpoints by type (4K Display, 4KIP Cameras, 4K Advanced Visualization Systems, and Others (4K Surgical Recorder, 4K Surgical Monitors) End User - Our Report covers by End Users in the 3 viewpoints (Hospitals, Diagnostic Centers and Others) Region - This Report covers Global 4K Medical Imaging Market breakup by 4 Region ( North America, Europe, Asia- Pacific and Rest of World) The key companies have been covered from 3 Viewpoints (Recent Development, Overview, and Revenue Analysis) Sony Corporation, B. Braun Melsungen, Stryker Corporation, Smith & Nephew plc, Eizo Corporation, Stryker, Conmed Corporation, Medtronic plc, Siemens Healthineers, Zimmer Biomet Holdings, Inc. About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND) Email: info@renub.com Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research Follow on Twitter: @renubresearch

According to Renub Research report, tittled “Cardiovascular Surgical Devices Market, Size, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” finds the Cardiovascular Surgical Devices Market was USD 49.77 Billion in 2021. Globally, cardiovascular diseases are common life-threatening acute diseases. The rise in chronic cardiovascular diseases like heart failure and coronary artery disease (CAD), heart attack, atrial fibrillation, the opening of narrowed arteries, and coronary heart diseases repeatedly require technologically advanced cardiovascular surgical devices. Thus, cardiovascular surgical devices are increasingly important in cardiovascular disease to reduce mortality and medical disability and have made significant contributions to patient care. Furthermore, perfusion disposables, cardiopulmonary bypass equipment, beating heart surgery treatment, and ventricular assist type devices help treat life-threatening cardiac diseases such as heart attack, atrial fibrillation, coronary heart diseases, and the opening of narrowed arteries. These surgical devices are utilized in cardiac surgery, one of their primary applications. These products also enable heart-lung machines employed during open-heart surgeries such as heart valve replacement, coronary artery bypass grafting, and other such procedures. Market Drivers of the Cardiovascular Surgical Devices Industry The majority of the deaths worldwide are due to cardiac diseases; according to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, 17.9 million people died from CVDs in 2019, representing 32% of all global deaths due to stroke and heart attack. These factors majorly propel the growth of the cardiovascular surgical devices market. Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=cardiovascular-surgical-device-market-p.php In addition, a rise in incidences of atherosclerosis, diabetes, hypertension, strokes, and other chronic disorders that occur due to change in lifestyle habits (such as unhealthy dietary habits, smoking, and lack of physical activity) also boosts the growth of the cardiac surgical devices industry. Worldwide Cardiovascular Surgical Device Market Size was US$ 49.77 Billion in 2021 Based on end-user, the cardiovascular surgical devices market is segregated into Hospitals, Cardiac Diagnostic Centers, and Ambulatory Surgical Centers. The high footfall, well-developed infrastructure, and increased healthcare expenditure have made the hospital the most preferred end-use extension. Further, a surge in the volume of surgeries due to the expanding prevalence of heart disorders and other diseases in hospitals is to boost the segment's development. Additionally, the increased demand for cardiac surgeries is expanding the number of operating rooms, aiding the part's development, correspondingly boosting the growth of the Global Cardiovascular Surgical Devices Industry. Cardiac Rhythm Management Devices are to Witness Rapid Growth: In terms of application, cardiac rhythm management (CRM) devices are extensively used to treat arrhythmia, tachycardia, bradycardia, and sudden cardiac arrests. Since the majority of cardiac rhythm conditions are growing, the adoption of cardiac management devices has improved significantly during the past decade. Besides, emerging nations are witnessing a huge demand for these devices due to a higher prevalence of cardiac conditions, raising awareness about products amongst the population. Besides, interventional cardiology surgery is the sub-specialty of cardiology that uses intravascular catheter-based techniques with fluoroscopy to treat coronary artery, valvular, and congenital cardiac diseases. North America is the Biggest Cardiovascular Surgical Devices Market Geographically, North America is an essential market for cardiovascular surgical devices due to the rising geriatric population and deaths related to cardiovascular disorders that demand cardiovascular surgical devices in the region. For instance, according to American Heart Association (AHA), 43.7 million aged above 60 suffer from cardiovascular disorders in the US. Due to these factors, many surgeries are being performed, thereby driving the market. Besides, countries like China, India, and Japan significantly demand cardiovascular surgical devices in Asia-Pacific due to the expanding prevalence of chronic cardiovascular diseases and the high adoption of advanced devices. Impact of Covid-19 on Cardiovascular Surgical Devices Industry The COVID-19 pandemic hit the production of cardiovascular surgical devices. The discontinuation of elective procedures due to COVID-19-related measures has negatively affected the cardiovascular surgical devices industry. While some cardiovascular systems are considered urgent, others have been postponed and delayed since the beginning of the global pandemic. Another factor negatively affecting the cardiovascular surgical devices market is reducing the diagnosis of cardiovascular diseases due to healthcare resources being reserved for COVID-19 patients. Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/cardiovascular-surgical-device-market-p.php Cardiovascular Surgical Devices Market: Key Players The global cardiovascular surgical devices sector is highly fragmented, with many players such as Abbott Laboratories, Boston Scientific Corporation, Edwards Life sciences, Cardinal Health Inc., Medtronic PLC, and GE Healthcare. Thus, global players are adopting mergers, acquisitions, and collaborations to expand their product offerings and customer base, expanding their market share. For instance, in 2020, Abbott announced the launch of its clip-delivery system to treat patients suffering from mitral regurgitation. Market Summary: Type – We have covered Global Cardiovascular Surgery Devices Market breakup by 4 viewpoints by Type (Perfusion Disposables, Cardiopulmonary Bypass Equipment, Beating Heart Surgery Treatment and Ventricular Assist Device) Application – This Report has covered Market breakup by 4 viewpoints (Interventional Cardiac Surgery, Cardiac Rhythm Management, Traditional Cardiac Surgery and Others) End User - Renub Research Report covered in the 3 viewpoints (Hospitals, Cardiac Diagnostic Centres and Ambulatory Surgical Centre) Regions – Our Report covers Global Cardiovascular Surgery Devices Market breakup by 4 Regions (North America, Europe, Asia Pacific and ROW) All the major companies have been covered from 3 Viewpoints (Recent Development, Overview, and Revenue Analysis) Abbott Laboratories, Boston Scientific Corporation, Edwards Life sciences, Cardinal Health Inc., Medtronic PLC and GE Healthcare. About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND) Email: info@renub.com Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research Follow on Twitter: @renubresearch

According to Renub Research report titled “Europe Olive Oil Market Forecast 2021-2027, Industry Trends, Share, Insight, Growth, Impact of COVID-19, Opportunity Company Analysis” the Europe Olive Oil Market Size will be US$ 7.35 Billion by 2027. For ages, the majority of world's olive oil market has revolved around the realms of European boundaries. Hence, Europe has remained the leading market for producing, consuming, importing, and exporting olive oil. In addition, mainly, the Mediterranean countries of Europe are dedicated to the cultivation of olives trees, combining traditional, intensive and super-intensive groves. Remarkably, demand for olive oil in Europe remains stable. However, import quantities sometimes are expected to fluctuate due to variable production in the central supplying countries of the region. Europe Olive Oil Market Size was US$ 3.86 Billion in 2020 The thriving consumer interest in olive oil in Europe has three main driving forces combined: the ever-increasing popularity of the Mediterranean diet, the increasing awareness of olive oil's health benefits and the quality of certain types of olive oil. In addition, the promotions of single-origin premium olive oil and sustainable and ethical production methods have been favourable aspects for well-established market culture in recent years. Besides, the best opportunities for the market come from a country like Spain, Italy, Greece and Portugal. The European market remains the number one producer, exporter and consumer of olive oil in the world. The producing countries account for millions of hectares of olive groves, primarily dedicated to olive oil production. In our report, four producing member states of Europe have been analyzed: Spain, Italy, Greece, and Portugal. As per our analysis, Spain accounts for the most dominant market share in the European region for olive oil. Moreover, in terms of trade, a strong demand spurred by consumer preferences will increase European exports. Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=europe-olive-oil-market-p.php Extra Virgin Olive Oil is anticipated for strong Performance in the Forecast Period: Eight different categories of olive oils and olive-pomace oils exist extra-virgin olive oil, virgin olive oil, virgin lampante olive oil, refined olive oil, olive oil composed of refined olive oil and pure olive oils, olive pomace oil, crude olive-pomace oil, refined olive pomace oil. However, all categories are unavailable to be sold to consumers. As per our analysis, Extra Virgin Oil, Virgin Oil, Lampante, Pomace are some prominent demanded oil readily demanded by the consumer level. Further, as per our analysis, virgin olive oils witness strong market share existence. Due to their expanding popularity among customers, Virgin olive oils are associated with spreading awareness concerning their health advantages in Europe. Omega-3 and oleic acid in virgin oil aid prevent lifestyle-related disorders such as obesity and cardiovascular complications. The extra virgin oil is anticipated to exhibit strong growth in Europe due to its high utilization in pharmaceuticals, cosmetics, and cooking. Additionally, European families use extra virgin oil for cooking; it is extensively used in personal care products like skincare for numerous purposes such as massages, sports injuries, and reducing muscle fatigue. Expanding Utilization of Olive Oil in European Retail and Foodservice Sector Propels Market Growth: Additionally, the growing awareness concerning the role of olive oil in maintaining good health has exceptionally boosted the demand for various types of olive oil in pharmaceuticals, cosmetics and cooking industries. On the other side, retail has survived one of the most dynamically advancing realms that enable enterprises in the olive oil market to constantly be on their toes to observe their aim customers and sustain a customized strategy. In addition, the foodservice sector in Europe utilized olive oil for salad dressing and preparing cold foods. Wherein, olive oil is widely used in the making of various food products, essentially healthy snacks. The expanding demand for healthy snacks amongst users has compelled manufacturers to consolidate nutrient-rich ingredients such as olive fruit oil to enhance the value of the final product. Key Players in the European Olive Oil Market: In our report, some of the market's key players embrace Deoleo, S.A, Del Monte Foods, Unilever Group, Semapa, Bunge Limited. Players in the Olive Oil Market affirm many essential strategies. For instance, in 2020, Deoleo, the world's leading olive oil producer with Bertolli extra virgin olive oil brands, drives biodiversity. Europe Olive Oil Industry recovering from Impact of COVID-19: The demand and sale of olive oil observed a sudden slump with the outbreak of the COVID-19 pandemic. Nationwide lockdown in several countries also resulted in the disruption of trade activities, which has slowed the growth of this industry. However, after months of market imbalance, 2021 marks a year tendering growth in the European Olive Oil Industry, concluding a positive note. Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/europe-olive-oil-market-p.php According to the market study done by Renub Research, the progress in the Covid-19 vaccination campaign in Europe has positively affected the recovery of the Olive Oil Industry. The reopening of the foodservice supply chain, the restaurant and hospitality (Horeca) sector, and easing travel restrictions are the major supporting end-users boosting the market growth. Market Summary: Volume Analysis: We have analysed the volume of Production, Consumption, Import and Export in Europe Olive Oil Market. Country: We have also studied the Olive Oil Production Volume in Spain, Italy, Greece, Portugal and Others. Type: In our report we have studied Extra Virgin Oil, Virgin Oil, Other (Lampante, Pomace, etc Industry: The report studies Pharmaceuticals, Cosmetics, Cooking and Others revolving industries of the market. End-User: We have studied Food Service, Food Processing and Retail as major end users of the market. Company: The report summarises Deoleo, S.A, Del Monte Foods, Unilever Group, Semapa, Bunge Limited as key market players. About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND) Email: info@renub.com Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research Follow on Twitter: @renubresearch